Quest Diagnostics (DGX) stock climbed slightly today, gaining just above 0% after a relatively quiet session. Investors seem to be weighing recent performance, as shares are up 17% year-to-date and ...
Guardant Health’s third quarter was marked by robust revenue growth and a positive market reaction, with outperformance ...
Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...